In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis

Akihiro Nishiguchi, Michiya Matsusaki, Mitsunobu Kano, Hiroshi Nishihara, Daisuke Okano, Yoshiya Asano, Hiroshi Shimoda, Satoko Kishimoto, Soichi Iwai, Mitsuru Akashi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Tumour models mimicking in vivo three-dimensional (3D) microenvironments are of increasing interest in drug discovery because of the limitations inherent to current models. For example, preclinical assays that rely on monolayer or spheroid cell cultures cannot easily predict 3D cancer behaviours because they have no vasculature. Furthermore, there are major differences in cancer behaviour between human and animal experiments. Here, we show the construction of 3D blood/lymph-vascularized human stromal tissues that can be combined with cancer cells to mimic dynamic metastasis for real-time throughput screening of secreted proteinases. We validated this tool using three human carcinoma cell types that are known to invade blood/lymph vessels and promote angiogenesis. These cell types exhibited characteristic haematogenous/lymphogenous metastasis and tumour angiogenesis properties. Importantly, these carcinoma cells selectively secreted different matrix metalloproteinases depending on their metastasis stage and target vasculature, suggesting the possibility of developing drugs that can target each secreted proteinase. We conclude that the 3D tissue tool will be a powerful throughput system for predicting cancer cell responses and time-dependent secretion of molecules in preclinical assays.

Original languageEnglish
Pages (from-to)144-155
Number of pages12
JournalBiomaterials
Volume179
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Lymph
Assays
Blood
Cells
Tissue
Neoplasm Metastasis
Tumors
Neoplasms
Secreted Matrix Metalloproteinases
Peptide Hydrolases
Throughput
Blood vessels
Cell culture
Carcinoma
Monolayers
Screening
Animals
Drug Discovery
Reaction Time
Molecules

Keywords

  • Extracellular matrix
  • In vitro tumour model
  • Layer-by-layer assembly
  • Metastasis
  • Nanofilm
  • Preclinical assay

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis. / Nishiguchi, Akihiro; Matsusaki, Michiya; Kano, Mitsunobu; Nishihara, Hiroshi; Okano, Daisuke; Asano, Yoshiya; Shimoda, Hiroshi; Kishimoto, Satoko; Iwai, Soichi; Akashi, Mitsuru.

In: Biomaterials, Vol. 179, 01.10.2018, p. 144-155.

Research output: Contribution to journalArticle

Nishiguchi, A, Matsusaki, M, Kano, M, Nishihara, H, Okano, D, Asano, Y, Shimoda, H, Kishimoto, S, Iwai, S & Akashi, M 2018, 'In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis', Biomaterials, vol. 179, pp. 144-155. https://doi.org/10.1016/j.biomaterials.2018.06.019
Nishiguchi, Akihiro ; Matsusaki, Michiya ; Kano, Mitsunobu ; Nishihara, Hiroshi ; Okano, Daisuke ; Asano, Yoshiya ; Shimoda, Hiroshi ; Kishimoto, Satoko ; Iwai, Soichi ; Akashi, Mitsuru. / In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis. In: Biomaterials. 2018 ; Vol. 179. pp. 144-155.
@article{871df9f16bea4d2cbd79f1cee3ce98a7,
title = "In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis",
abstract = "Tumour models mimicking in vivo three-dimensional (3D) microenvironments are of increasing interest in drug discovery because of the limitations inherent to current models. For example, preclinical assays that rely on monolayer or spheroid cell cultures cannot easily predict 3D cancer behaviours because they have no vasculature. Furthermore, there are major differences in cancer behaviour between human and animal experiments. Here, we show the construction of 3D blood/lymph-vascularized human stromal tissues that can be combined with cancer cells to mimic dynamic metastasis for real-time throughput screening of secreted proteinases. We validated this tool using three human carcinoma cell types that are known to invade blood/lymph vessels and promote angiogenesis. These cell types exhibited characteristic haematogenous/lymphogenous metastasis and tumour angiogenesis properties. Importantly, these carcinoma cells selectively secreted different matrix metalloproteinases depending on their metastasis stage and target vasculature, suggesting the possibility of developing drugs that can target each secreted proteinase. We conclude that the 3D tissue tool will be a powerful throughput system for predicting cancer cell responses and time-dependent secretion of molecules in preclinical assays.",
keywords = "Extracellular matrix, In vitro tumour model, Layer-by-layer assembly, Metastasis, Nanofilm, Preclinical assay",
author = "Akihiro Nishiguchi and Michiya Matsusaki and Mitsunobu Kano and Hiroshi Nishihara and Daisuke Okano and Yoshiya Asano and Hiroshi Shimoda and Satoko Kishimoto and Soichi Iwai and Mitsuru Akashi",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.biomaterials.2018.06.019",
language = "English",
volume = "179",
pages = "144--155",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis

AU - Nishiguchi, Akihiro

AU - Matsusaki, Michiya

AU - Kano, Mitsunobu

AU - Nishihara, Hiroshi

AU - Okano, Daisuke

AU - Asano, Yoshiya

AU - Shimoda, Hiroshi

AU - Kishimoto, Satoko

AU - Iwai, Soichi

AU - Akashi, Mitsuru

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Tumour models mimicking in vivo three-dimensional (3D) microenvironments are of increasing interest in drug discovery because of the limitations inherent to current models. For example, preclinical assays that rely on monolayer or spheroid cell cultures cannot easily predict 3D cancer behaviours because they have no vasculature. Furthermore, there are major differences in cancer behaviour between human and animal experiments. Here, we show the construction of 3D blood/lymph-vascularized human stromal tissues that can be combined with cancer cells to mimic dynamic metastasis for real-time throughput screening of secreted proteinases. We validated this tool using three human carcinoma cell types that are known to invade blood/lymph vessels and promote angiogenesis. These cell types exhibited characteristic haematogenous/lymphogenous metastasis and tumour angiogenesis properties. Importantly, these carcinoma cells selectively secreted different matrix metalloproteinases depending on their metastasis stage and target vasculature, suggesting the possibility of developing drugs that can target each secreted proteinase. We conclude that the 3D tissue tool will be a powerful throughput system for predicting cancer cell responses and time-dependent secretion of molecules in preclinical assays.

AB - Tumour models mimicking in vivo three-dimensional (3D) microenvironments are of increasing interest in drug discovery because of the limitations inherent to current models. For example, preclinical assays that rely on monolayer or spheroid cell cultures cannot easily predict 3D cancer behaviours because they have no vasculature. Furthermore, there are major differences in cancer behaviour between human and animal experiments. Here, we show the construction of 3D blood/lymph-vascularized human stromal tissues that can be combined with cancer cells to mimic dynamic metastasis for real-time throughput screening of secreted proteinases. We validated this tool using three human carcinoma cell types that are known to invade blood/lymph vessels and promote angiogenesis. These cell types exhibited characteristic haematogenous/lymphogenous metastasis and tumour angiogenesis properties. Importantly, these carcinoma cells selectively secreted different matrix metalloproteinases depending on their metastasis stage and target vasculature, suggesting the possibility of developing drugs that can target each secreted proteinase. We conclude that the 3D tissue tool will be a powerful throughput system for predicting cancer cell responses and time-dependent secretion of molecules in preclinical assays.

KW - Extracellular matrix

KW - In vitro tumour model

KW - Layer-by-layer assembly

KW - Metastasis

KW - Nanofilm

KW - Preclinical assay

UR - http://www.scopus.com/inward/record.url?scp=85053202993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053202993&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2018.06.019

DO - 10.1016/j.biomaterials.2018.06.019

M3 - Article

C2 - 29986232

AN - SCOPUS:85053202993

VL - 179

SP - 144

EP - 155

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -